Atgc Biotech Private Limited - Due diligence report

A 360° intelligence report on Atgc Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals -…

2011-06-20 Hyderabad, Telangana Active Unlisted Active Compliant
Share
Connect MCP
AB Atgc Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Atgc Biotech — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Atgc Biotech is assessed as Low Risk with a Trust Score of 78/100. Atgc Biotech is an active private limited indian non-government company incorporated in 2011, operating in the Life Sciences sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Atgc Biotech Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 3 open (15.08 cr) · 1 satisfied (10.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Hdfc Bank Limited2 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
AKSHITHA KAUKUTTLA REDDY 01234567 Director 01/04/2018 6 yrs Approved
VIJAYA BHASKER REDDY LACHAGARI 01234567 Director 01/04/2018 6 yrs Approved
MARKANDEYA GORANTLA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: MARKANDEYA GORANTLA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 75
Growth signals & trust indicators
Net margin improved to 2.1x.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 15.08 cr already registered.
  • Compliance record supports lending.
Investor view55/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
08 Aug 2025
Director appointed
AKSHITHA KAUKUTTLA REDDY (Additional Director)
Director appointed
VIJAYA BHASKER REDDY LACHAGARI (Additional Director)
15 May 2025
Charge satisfied
Hdfc Bank Limited
31 Mar 2025
Charge created
Others - 10.00 cr
Charge created
Others - 5.00 cr
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
19 Jan 2024
Charge created
Hdfc Bank Limited - 10.00 cr
30 Sep 2023
Director ceased
SATYA BHASKAR CHALASANI
10 May 2021
Charge created
Hdfc Bank Limited - 7.59 Lakh
06 Apr 2021
Director ceased
ARJULA RAMACHANDRA REDDY
28 Sep 2018
Director ceased
MARKANDEYA GORANTLA
29 Sep 2017
Director ceased
KAUKUTTLA ANANTHA REDDY
18 Sep 2017
Director ceased
RAMA KRISHNA REDDY PINGILI
08 May 2017
Director ceased
ANANTHA REDDY BADDAM
10

Key Observations

Auto-generated from the data above
Revenue declined 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
V2S Polypack Private Limited U74999TN2020PTC135558 Chengalpattu, Tamil Nadu, India
Institute Of Life Sciences U73100TG2003NPL042023 Hydererabad, Telangana, India
Asmaitha U32103KA2010PTC053440 Bangalore, Karnataka, India
St. Stone Medical Devices Private Limited U24230MN2012PTC008315 Kakching, Manipur, India
Aco Technology Centre Private Limited U74900KA2010FTC052125 Banglore, Karnataka, India
Globalgenecorp U73100MH2013FTC300725 Mumbai, Maharashtra, India
Hd Hyundai Technology Center India Private Limited U74999PN2019FTC185992 Pune, Maharashtra, India
Caraway Development Centre (India) Private Limited U15400KA2014FTC077745 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Atgc Biotech before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Atgc Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Atgc Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Atgc Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Atgc Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Atgc Biotech an active company?

Atgc Biotech has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Atgc Biotech financially healthy?

Atgc Biotech has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Atgc Biotech?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Atgc Biotech?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Atgc Biotech have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Atgc Biotech up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Atgc Biotech?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.